KAPANYSE

Kairos Pharma, LTD.

Pharmaceutical Preparations · DE · CIK 1962011

Kairos Pharma advances therapeutics for cancer patients designed to overcome immune suppression and drug resistance

$9M

Market cap

$0.38

Last close

+7.5%

-10.2%

112K

Volume

Price · last 40 sessions-31.8%

May 4L $0.35 · H $0.56Jun 30

Total filings

Jun 30, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance